Hikma Pharmaceuticals PLC (HIK)

Industry Drug Manufacturers - Specialty & Generic
This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

2,072.00p

Buy

2,076.00p

arrow-up143.00p (+7.37%)

Prices updated at 15 May 2025, 17:23 BST
| Prices minimum 15 mins delay
|
Prices in GBX
Hikma Pharmaceuticals PLC develops, manufactures and markets a broad range of branded and non-branded generic pharmaceutical products across the US, the MENA region, and Europe.
FTSE All-Share
arrow-up0.5%
LSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Chairman
Mr. Said Darwazah
CEO
Mr. Riad Mishlawi
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
9,500
Head office
1 New Burlington Place
London
United Kingdom
W1S 2HR
mobile
+44 2073992760
letter
investors@hikma.uk.com
computer
Company website

Key personnel

Owner name
chevron-l-regular
chevron-r-regular
Salary
Mr. Mohammed Ali Khaldoun S Al-Husry
Non-Executive Director
-
Mr. Douglas Michael Hurt
Non-Executive Director
-
Ms. Nina Henderson
Non-Executive Director
-
Mr. John Julius Castellani
Non-Executive Director
-
Ms. Cynthia L. Flowers
Non-Executive Director
-
Dr. Deneen Vojta, M.D.
Non-Executive Director
-
Mr. Mazen Samih Taleb Darwazah
Executive Director, Vice Chairman
-
Mr. Riad Mishlawi
Executive Director, Chief Executive Officer
-
Mr. Said Darwazah
Executive Director, Chairman
-

Top 5 shareholders

Owner name
chevron-l-regular
chevron-r-regular
No. of shares
Vanguard Group Inc4,685,005
Mawer Investment Management Ltd3,829,539
Mawer Global Small Cap Fund3,558,892
Royal London Asset Management Ltd3,095,118
BlackRock Fund Advisors2,994,198

Director dealings

Date
chevron-l-regular
chevron-r-regular
Action
06 May 2025D
28 Feb 2025Transfer in
28 Feb 2025Transfer in
28 Feb 2025Transfer in
28 Feb 2025Exercise of Option
23 Sep 2024D
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.